Use of interleukin-10 to produce a population of suppressor cells
US6277635A · kind A · utility
3Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1996 |
| Grant date | Aug 21, 2001 |
| Priority date | — |
| Expiry date | May 6, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/515
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Interleukin-10 for producing a population of cells which are capable of inhibiting or suppressing reactions to alloantigens, for example in graft-versus-host disease or tissue rejection, is described. Interleukin-10 for reducing responses in mixed lymphocyte response (MLR) is also described. Exogenous or induced endogenous IL-10 may be used for the inhibition or suppression of the reactions to alloantigens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.